/Companies

Telemachus Therapeutics

Pittsburgh, US · Founded 2026

Find your way into Telemachus Therapeutics

Sign up to see every warm intro you have to Telemachus Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Telemachus Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MB
Michael BozikNamed on SEC filing
GH
Gregory HebrankNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$375K disclosed across 1 round · 2026

▶$375KraisedOct 2026 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BozikExecutive Officer, Director, Promoter
  • Gregory HebrankExecutive Officer, Director, Promoter
Offering amount
$1.5M
Amount sold
$375K
Minimum investment
$50K
Proceeds to insiders
$250K
First sale
Aug 2026
Incorporated
Corporation, Delaware, 2026
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Telemachus Therapeutics raised?
Telemachus Therapeutics has disclosed $375K raised across 1 round.
Where is Telemachus Therapeutics headquartered?
Telemachus Therapeutics is headquartered in Pittsburgh, US.